• SENSEX 76,755.05
    -715.06 (--0.92%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,956.00 2,174.70(%)
  • Bluestone Jewel
    872.60 872.60(%)
  • Anthem Bioscienc
    735.10 579.45(%)
  • IndusInd Bank
    1,077.80 1,077.80(%)
  • M & M Fin. Serv.
    384.55 412.30(%)
  • Data Pattern
    4,800.00 4,955.00(%)
  • TVS Motor Co.
    3,965.00 3,970.00(%)
  • Cummins India
    5,635.00 6,142.80(%)
  • Bajaj Auto
    11,025.00 11,025.00(%)
  • SBI Funds Mgt.
    582.55 582.55(%)
  • Bandhan Bank
    169.65 134.30(%)
  • HDFC Bank
    750.25 726.75(%)
  • Kalyan Jewellers
    601.25 617.30(%)
  • Eternal
    275.70 212.55(%)
  • Reliance Industries
    1,284.00 1,253.65(%)
  • Bajaj Finance
    1,056.30 788.40(%)
  • Dixon Technolog.
    13,650.00 9,605.05(%)
  • Himadri Special
    760.20 420.00(%)
  • Titan Company
    4,730.10 4,730.10(%)
  • Nestle India
    1,509.75 1,509.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Colinz Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5989.0
  • ISIN : INE923C01011
80.13 -2 (-2.28%)
  • As on 23 Jul 2026 (EOD)
  • Today’s Low

    77.90
  • Today’s High

    84.45
  • Open

    82.00
  • Perv Close

    82.00
  • 52W Low

    36.11
  • 52W High

    87.91

Key Indicators

  • P/E(TTM)

    19.64

  • Mar.Cap (₹Cr.)

    10.09

  • Div & Yield %

    0.00

  • Book Value(₹)

    69.70

  • Debt-Equity Ratio

    -2.28

  • AGM Date

    22-Jul-2026

  • EPS

    4.08

  • P/E Ratio

    19.64

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    10.09

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    1.26

  • BV (₹)

    69.70

  • Sales( ₹ in Cr.)

    6.14

  • NP (in Cr.)

    0.51

  • NP Var(%)

    3.0

  • Div%

    0.0

  • CPS (₹)

    5.30

  • EPS (₹)

    4.10

  • Traded Value (₹ in Lakhs)

    10.09

  • 52 Week High

    87.91

  • 52 Week Low

    36.11

  • Price BSE

    80.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    10.09

  • P/C Ratio

    15.00

  • P/E Ratio

    19.60

  • Price Vs.BV

    4.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 6.53 7.03 7.15 6.97 6.16 7.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.07
Net Sales 6.53 7.03 7.15 6.97 6.16 7.53
Other Income 0.30 0.28 0.17 0.17 0.19 0.13
Stock Adjustments -0.08 -0.08 0.03 -0.33 -0.47 -0.12
Total Income 6.75 7.23 7.35 6.81 5.88 7.54
EXPENDITURE :            
Raw Materials 2.01 2.23 2.33 1.97 1.72 2.62
Power and Fuel Cost 0.12 0.11 0.11 0.08 0.08 0.09
Employee Cost 2.67 2.79 2.90 2.77 2.39 3.25
Other Manufacturing Expenses 0.10 0.23 0.14 0.14 0.13 0.06
Selling and Administration Expenses 1.05 1.04 1.08 1.03 0.96 1.08
Miscellaneous Expenses 0.01 0.00 0.03 0.06 0.09 0.01
Employee Benefit Expenses 2.67 2.79 2.90 2.77 2.39 3.25
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5.95 6.40 6.58 6.06 5.36 7.11
Operating Profit 0.79 0.82 0.78 0.76 0.53 0.44
Interest 0.04 0.04 0.05 0.08 0.09 0.07
Gross Profit 0.75 0.78 0.73 0.68 0.44 0.37
Depreciation 0.13 0.13 0.13 0.20 0.19 0.19
Profit Before Tax 0.62 0.65 0.60 0.48 0.25 0.18
Current Tax 0.18 0.18 0.16 0.15 0.08 0.07
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.05 -0.01 -0.02 -0.01 -0.04 -0.02
Reported Net Profit 0.50 0.49 0.46 0.34 0.21 0.13
Extraordinary Items 0.00 0.00 -0.02 0.00 0.00 0.00
Adjusted Net Profit 0.50 0.49 0.48 0.34 0.21 0.13
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 2.96 2.47 2.01 1.67 1.47 1.34
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 3.45 2.96 2.47 2.01 1.67 1.47
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.97 1.93 1.82 0.96 0.59 0.37
Earnings Per Share(Adj)-Unit Curr 1.97 1.93 1.82 0.96 0.59 0.37
Book Value 37.61 35.52 32.31 21.69 20.57 19.29
Book Value(Adj)-Unit Curr 37.61 35.52 32.31 21.69 20.57 19.29

Shareholding Pattern

  • Promoter Group

    50.60%

  • Public Share Holding

    49.40%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,274,659 50.60 881,159 154
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,274,659 50.60 881,159 154
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 27,194 1.08 21,894 17
Clearing Members 8,954 0.36 8,954 2
Directors of their Relatives 0 0.00 0 0
Employees 3,500 0.14 300 17
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 14,693 0.58 3,993 30
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 26,420 1.05 26,420 35
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 420,440 16.69 420,440 4
Individuals holding nominal share capital up to Rs. 1 lakh 743,240 29.50 497,155 2,915
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,244,441 49.40 979,156 3,020
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 2,519,100 100.00 1,860,315 3,174

Company Background

Colinz Laboratories LtdPharmaceuticals - Indian - Formulations

  • Colinz Laboratories Ltd
  • BSE Code : 5989.0
  • ISIN : INE923C01011
  • Incorporation Year

    1986

  • Registered Office

    A-101 Pratik Industrial Estate
    Mulund Goregaon Link Road, Mumbai,
    Maharashtra-400078

  • Telephone

    91-022-25668002/8003

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Falguni Kumawat

  • Auditor

    Vora & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Colinz Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Colinz Labs 80.13 6.83 6.53 19.64 6.72
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Fermenta Biotec. 420.85 442.21 430.53 19.27 17.61
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77